Skip to main content
. 2020 Jun 12;11:1186. doi: 10.3389/fimmu.2020.01186

Figure 7.

Figure 7

Quantitative measurement of pro-inflammatory LMs and SPMs in mouse WLL fluids. Mice were treated as described in Figure 2 legend and were examined for the levels of specialized LMs in the WLL fluid. Proinflammatory LMs LTB4 (A) and PGE2 (B), or SPMs RvD1 (C), LXA4 (D), and RvE1 (E) were quantitatively measured using ELISA (n = 6). The ratio of fold change for RvD1/LTB4 (F) or RvD1/PGE2 (G) was further calculated for MWCNT- or C60F-treated samples at day 1 and day 7. *p < 0.05; **p < 0.01; ***p < 0.001.